# Dexmedetomidine and Ketamine in VATS Surgery

> **NCT03596424** · NA · RECRUITING · sponsor: **Ciusss de L'Est de l'Île de Montréal** · enrollment: 120 (estimated)

## Conditions studied

- Postoperative Pain
- Opioid Use

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **DRUG:** Dexmedetomidine Hydrochloride
- **COMBINATION_PRODUCT:** dexmedetomidine Hydrochloride and Ketamine Hydrochloride

## Key facts

- **NCT ID:** NCT03596424
- **Lead sponsor:** Ciusss de L'Est de l'Île de Montréal
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-02-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-07-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03596424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03596424, "Dexmedetomidine and Ketamine in VATS Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03596424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
